Methylgene's PIPE - II Round

Methylgene raised a round of funding on November 26, 2012.

TSE: MYG Biopharmaceutical company focused on the discovery, development and commercialization of novel enzyme inhibitors for the treatment of cancer and infectious diseases. The company uses function…

Articles about Methylgene's PIPE - II Round: